264 related articles for article (PubMed ID: 17255787)
21. Gene expression profiling in acute myeloid leukaemia (AML).
Bacher U; Kohlmann A; Haferlach C; Haferlach T
Best Pract Res Clin Haematol; 2009 Jun; 22(2):169-80. PubMed ID: 19698926
[TBL] [Abstract][Full Text] [Related]
22. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Larson RA
Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
[TBL] [Abstract][Full Text] [Related]
23. Progress and strategies for patients with relapsed and refractory acute myeloid leukemia.
Litzow MR
Curr Opin Hematol; 2007 Mar; 14(2):130-7. PubMed ID: 17255790
[TBL] [Abstract][Full Text] [Related]
24. New insights into the biology of acute myeloid leukemia and their impact on treatment.
Hiddemann W; Haferlach T; Schoch C; Behre G; Kohlmann A; Kern W; Feuring-Buske M; Bohlander S
Verh Dtsch Ges Pathol; 2003; 87():72-8. PubMed ID: 16888897
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia.
Heerema-McKenney A; Arber DA
Hematol Oncol Clin North Am; 2009 Aug; 23(4):633-54. PubMed ID: 19577162
[TBL] [Abstract][Full Text] [Related]
26. BAALC and ERG expression in acute myeloid leukemia with normal karyotype: impact on prognosis.
Eid MA; Attia M; Abdou S; El-Shazly SF; Elahwal L; Farrag W; Mahmoud L
Int J Lab Hematol; 2010 Apr; 32(2):197-205. PubMed ID: 19555438
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability and p53 mutations are characteristic of subgroups of acute myeloid leukemia but independent events.
Herzog G; Lu-Hesselmann J; Zimmermann Y; Haferlach T; Hiddemann W; Dreyling M
Haematologica; 2005 May; 90(5):693-5. PubMed ID: 15921389
[TBL] [Abstract][Full Text] [Related]
28. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic impact of karyotype in de novo acute myeloid leukemia: study of 139 cases].
Sennana Sendi H; Elghezal H; Temmi H; Gribaa M; Laatiri A; Ben Abid H; Ben Abdeladhime A; Elloumi M; Hafsia A; Saad A
Tunis Med; 2002 Sep; 80(9):531-5. PubMed ID: 12632766
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in acute myeloid leukaemia.
Löwenberg B
Best Pract Res Clin Haematol; 2001 Mar; 14(1):65-75. PubMed ID: 11355924
[TBL] [Abstract][Full Text] [Related]
31. Acquired chromosomal rearrangements targeting selected transcription factors: contribution of molecular cytogenetic and expression analyses to the identification of clinically and biologically relevant subgroups in hematological malignancies.
Poppe B; De Paepe A; Speleman F
Verh K Acad Geneeskd Belg; 2007; 69(1):47-64. PubMed ID: 17427874
[TBL] [Abstract][Full Text] [Related]
32. Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.
Mori Y; Yoshimoto G; Kumano T; Miyamoto T; Iino T; Takenaka K; Iwasaki H; Harada N; Kinukawa N; Nagafuji K; Teshima T; Shimoda K; Akashi K; Harada M
Eur J Haematol; 2007 Jul; 79(1):17-24. PubMed ID: 17598835
[TBL] [Abstract][Full Text] [Related]
33. Chromosome aberrations in de novo acute myeloid leukemia patients in Kuwait.
Al Bahar S; Pandita R; Bavishi K; Kreze O; Nath S
Neoplasma; 2004; 51(3):223-7. PubMed ID: 15254677
[TBL] [Abstract][Full Text] [Related]
34. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
[TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of the most common chromosome translocations in adult acute myeloid leukemia.
Mrózek K; Bloomfield CD
J Natl Cancer Inst Monogr; 2008; (39):52-7. PubMed ID: 18648004
[TBL] [Abstract][Full Text] [Related]
37. Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study.
Radmacher MD; Marcucci G; Ruppert AS; Mrózek K; Whitman SP; Vardiman JW; Paschka P; Vukosavljevic T; Baldus CD; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD;
Blood; 2006 Sep; 108(5):1677-83. PubMed ID: 16670265
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of N-RAS and K-RAS mutations in 232 patients with acute myeloid leukemia.
Ritter M; Kim TD; Lisske P; Thiede C; Schaich M; Neubauer A
Haematologica; 2004 Nov; 89(11):1397-9. PubMed ID: 15531466
[TBL] [Abstract][Full Text] [Related]
39. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
40. Acute myeloid leukemia: advances in diagnosis and classification.
Hasserjian RP
Int J Lab Hematol; 2013 Jun; 35(3):358-66. PubMed ID: 23590662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
